New ulcerative colitis drug faces Year-Long safety check
NCT ID NCT07459686
Summary
This study will monitor the safety and effectiveness of Velsipity tablets over one year in patients with moderate to severe ulcerative colitis. Researchers will track 553 patients taking the medication in real-world medical settings to identify any long-term side effects. The main goal is to understand how safe the drug is during extended use while also checking if it helps control symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.